➤ How does Phase III differ from Phase II and Phase IV trials?
Phase II tests preliminary efficacy, dose selection, and short‑term safety in a moderate number of patients. Phase III expands to larger populations to confirm efficacy and characterize safety across subgroups. Phase IV occurs after approval and focuses on real‑world safety, rare adverse events, long‑term outcomes, and effectiveness in broader populations.
Leave a Reply